Literature DB >> 17984687

Treatment of thalassemia with hydroxyurea: an indispensable alternative therapy.

Antonis Kattamis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17984687     DOI： 10.1097/MPH.0b013e3181583b46

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  2 in total

1.  Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran.

Authors:  Mehran Karimi; Sezaneh Haghpanah; Ali Farhadi; Majid Yavarian
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.

Authors:  Maryam Khavari; Azin Hamidi; Sezaneh Haghpanah; Mohammad Hadi Bagheri; Marzieh Bardestani; Razieh Hantooshzadeh; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2014-07-05       Impact factor: 0.611
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.